Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling

Cited by (339)

Items 101–200 of 339

1. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death
   Pradeep Natarajan, T. Collier, Zhicheng Jin, Asya Lyass, Yiwei Li, Nasrien E. Ibrahim, Renata Mukai, Cian P. McCarthy, Joseph M. Massaro, Ralph B. D’Agostino et al. · 2019 · Journal of the American College of Cardiology
2. The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
   Guilaine K. Boyce, Emily B. Button, S.V. Sonja, Cheryl Lea Wellington · 2017 · Journal of Biomedical Research
3. The effect of chronic kidney disease on lipid metabolism
   Neris Di̇nçer, Tuncay Dağel, Barış Afşar, Adrian Constantin Covic, Alberto Ortíz, Mehmet Kanbay · 2018 · International Urology and Nephrology
4. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
   Wen Dai, Ziyu Zhang, Chun Yao, Shui‐Ping Zhao · 2019 · Lipids in Health and Disease
5. Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties
   Chantal Kopecky, Michael Haidinger, Ruth Birner‐Gruenberger, Barbara Darnhofer, Christopher C. Kaltenecker, Gunther Marsche, Michael Holzer, Thomas Weichhart, Marlies Antlanger, Johannes Josef Kovarik et al. · 2014 · Journal of the American Society of Nephrology
6. High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response
   Natalia A. Taborda, Yurany Blanquiceth, Silvio Urcuqui Inchima, Eicke Latz, Juan Carlos Hernández · 2019 · Journal of Interferon & Cytokine Research
7. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL
   Nicholas Hui, Philip J. Barter, Kwok Leung Ong, Kerry‐Anne Rye · 2019 · Clinical Science
8. Dysfunctional high-density lipoprotein: an updated review
   Frances W. Ouyang, Huan‐Hsing Chiang, Wen‐Li Hsu, Ming-Hsien Tsai, Chun-Yao Huang, Alan Thomas Remaley, Ömer Akyol, Chu‐Huang Chen · 2025 · Frontiers in Cardiovascular Medicine
9. Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment
   David Bar‐Or, Leonard T. Rael, Gregory W. Thomas, Edward N. Brody · 2015 · Current Rheumatology Reviews
10. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia
    Ioanna Gouni‐Berthold · 2017 · Atherosclerosis Supplements
11. Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
    Cristina Colom, David Viladés, Montserrat Pérez‐Cuellar, Rubén Leta, Andrea Rivas-Urbina, Gemma Carreras, Jordi Ordóñez‐Llanos, Antonio Pérez, José Luis Sánchez‐Quesada · 2018 · Cardiovascular Diabetology
12. Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients
    Hua-Ming Li, Zhi-Wei Mo, Yue-Ming Peng, Yan Li, Wei-Ping Dai, Haiyun Yuan, Feng-Jun Chang, Tiantian Wang, Mian Wang, Kun-Hua Hu et al. · 2020 · Redox Biology
13. Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle
    Jincui Huang, Hye‐Young Lee, Angela M. Zivkovic, Jennifer T. Smilowitz, Nancy Rivera, J. Bruce German, Carlito B. Lebrilla · 2014 · Journal of Proteome Research
14. Retinal Vein Occlusion is Associated with Low Blood High-Density Lipoprotein Cholesterol: A Nationwide Cohort Study
    Jaeryung Kim, Dong Hui Lim, Kyungdo Han, Se Woong Kang, Don‐Il Ham, Sang Jin Kim, Tae-Young Chung · 2019 · American Journal of Ophthalmology
15. High-density lipoprotein remodelled in hypercholesterolaemic blood induce epigenetically driven down-regulation of endothelial HIF-1α expression in a preclinical animal model
    Soumaya Ben‐Aicha, Rafael Escate, Laura Casaní, Teresa Padró, Esther Peña, Gemma Arderiu, Guiomar Mendieta, Lina Badimón, Gemma Vilahur · 2019 · Cardiovascular Research
16. Intake of cooked tomato sauce preserves coronary endothelial function and improves apolipoprotein A-I and apolipoprotein J protein profile in high-density lipoproteins
    Gemma Vilahur, Judit Cubedo, Teresa Padró, Laura Casaní, Guiomar Mendieta, Alicia González, Lina Badimón · 2014 · Translational research
17. High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality
    Günther Silbernagel, Philipp Pagel, Volker Pfahlert, Bernd Genser, Hubert Scharnagl, Marcus Edi Kleber, Graciela Delgado, Haruna Ohrui, Andreas Ritsch, Tanja B. Grammer et al. · 2017 · Clinical Chemistry
18. Clusterin in the eye: An old dog with new tricks at the ocular surface
    M. Elizabeth Fini, Aditi Bauskar, Shinwu Jeong, Mark R. Wilson · 2016 · Experimental Eye Research
19. HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction
    Alexandre Soares, Thauany Martins Tavoni, Eliane C. de Faria, Alan T. Remalay, Raul Cavalcante Maranhão, Andrei Carvalho Sposito · 2017 · Clinica Chimica Acta
20. Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
    Israa Dib, Alia Khalil, Racha Chouaib, Yolla El-Makhour, Hiba Noureddine · 2021 · Molecular Biology Reports
21. Clusterin/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation
    Maria Martínez-Bujidos, Anna Rull, Beatriz González‐Cura, Montserrat Pérez‐Cuellar, Laia Montoliu‐Gaya, Sandra Villegas, Jordi Ordóñez‐Llanos, José Luis Sánchez‐Quesada · 2014 · The FASEB Journal
22. Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
    Anabel García‐Heredia, Judit Marsillach, Anna Rull, Iris Triguero, Isabel Fort-Gallifa, Bharti Mackness, Mike Mackness, Diana M. Shih, Jorge Joven, Jordi Camps · 2013 · Mediators of Inflammation
23. Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity
    Michael Holzer, Sabine Kern, Ruth Birner‐Gruenberger, Sanja Ćurčić, Ákos Heinemann, Gunther Marsche · 2016 · Scientific Reports
24. Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency
    Takeshi Okada, Tohru Ohama, Kazuaki Takafuji, Kotaro Kanno, Hibiki Matsuda, Masami Sairyo, Yinghong Zhu, Ayami Saga, Takuya Kobayashi, Daisaku Masuda et al. · 2019 · Journal of clinical lipidology
25. Good Cholesterol Gone Bad? HDL and COVID-19
    George Eduardo Gabriel Kluck, Jeong‐Ah Yoo, Emmanuel H. Sakarya, Bernardo L. Trigatti · 2021 · International Journal of Molecular Sciences
26. Clusterin, other extracellular chaperones, and eye disease
    Mark R. Wilson, Sandeep Satapathy, Shinwu Jeong, M. Elizabeth Fini · 2021 · Progress in Retinal and Eye Research
27. ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future
    Arzu Kalaycı, Charles Michael Gibson, Paul M. Ridker, Samuel D. Wright, Bronwyn A. Kingwell, Serge Korjian, Gerald Chi, Jane Lee, Pierluigi Tricoci, Syed Hassan A. Kazmi et al. · 2022 · Current Atherosclerosis Reports
28. Balancing cholesterol in the brain: from synthesis to disposal
    Qian, Lydia, Chai, Amanda B., Gelissen, Ingrid C., Brown, Andrew J. · 2022 · Exploration of Neuroprotective Therapy
29. Apolipoprotein J
    Ning Yang, Qin Qin · 2015 · Chinese Medical Journal
30. Does high-density lipoprotein protect vascular function in healthy pregnancy?
    Wan N. Wan Sulaiman, MURIEL J. CASLAKE, Christian Delles, Helén Karlsson, Monique T Mulder, Delyth Graham, Dilys J. Freeman · 2016 · Clinical Science
31. HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants
    Michael Holzer, Sabine Kern, Markus Trieb, Athina Trakaki, Gunther Marsche · 2017 · Journal of Lipid Research
32. Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII
    Bettina Hieronimus, Kimber L. Stanhope · 2019 · Current Opinion in Lipidology
33. Cholesterol Efflux Capacity
    Amit V. Khera, Daniel James Rader · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
34. HDL and Atherothrombotic Vascular Disease
    Wijtske Annema, Arnold von Eckardstein, Petri T. Kovanen · 2014 · Handbook of experimental pharmacology
35. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
    Xiaowei Xiong, Hong Liu, Lu Hua, Hui Zhao, Dongxue Wang, Yishi Li · 2015 · Lipids in Health and Disease
36. HDL maturation and remodelling
    Kwok Leung Ong, Blake J. Cochran, Bikash Manandhar, Shane Ross Thomas, Kerry‐Anne Rye · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
37. Low High-Density Lipoprotein and Risk of Myocardial Infarction
    A. Ramirez, P. P. Hu · 2015 · Clinical Medicine Insights Cardiology
38. Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate
    Laurence Perségol, Maryam Darabi, Carolane Dauteuille, Marie Lhomme, Sandrine Chantepie, Kerry‐Anne Rye, Patrice Thérond, M. John Chapman, Robert Salvayre, Anne Nègre‐Salvayre et al. · 2017 · Journal of Lipid Research
39. Modified lipoproteins in periodontitis: a link to cardiovascular disease?
    Stefan Ljunggren, Torbjörn Bengtsson, Helén Karlsson, Carin Starkhammar Johansson, E. C. Palm, Fariba Nayeri, Bijar Ghafouri, Julia R. Davies, Gunnel Svensäter, Johanna Lönn · 2019 · Bioscience Reports
40. Biological factors in plasma from diabetes mellitus patients enhance hyperglycaemia and pulsatile shear stress-induced endothelial cell apoptosis
    X. F. Liu, J. Q. Yu, Rinkoo Dalan, A. Q. Liu, Kathy Qian Luo · 2014 · Integrative Biology
41. Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
    Mohammad Al Zein, Alicia Khazzeka, Alessandro El Khoury, Jana Al Zein, Zoghaib Dima, Ali Hussein Eid · 2024 · Progress in Cardiovascular Diseases
42. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease
    Virginia Hernández–Gea, Genís Campreciós, Fabián Betancourt, Valeria Pérez‐Campuzano, Susana Seijó, Alba Díaz, Rocío Gallego‐Durán, Pol Olivas, Lara Orts, Marta Magaz et al. · 2021 · Journal of Hepatology
43. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation
    Erik Walter Holy, Christian Besler, Martin F. Reiner, Giovanni Guido Camici, Jasmin Manz, Jürg Hans Beer, Thomas Felix Lüscher, Ulf Landmesser, Felix Christoph Tanner · 2014 · Thrombosis and Haemostasis
44. APOC3 induces endothelial dysfunction through TNF-α and JAM-1
    Yun Tao, Yi-song Xiong, Huimin Wang, Shao-peng Chu, Renqian Zhong, Jianxin Wang, Guihua Wang, Xiumei Ren, Juan Yu · 2016 · Lipids in Health and Disease
45. Interdependencies among Selected Pro-Inflammatory Markers of Endothelial Dysfunction, C-Peptide, Anti-Inflammatory Interleukin-10 and Glucose Metabolism Disturbance in Obese Women
    Joanna Janowska, Jerzy Tadeusz Chudek, Magdalena Olszanecka‐Glinianowicz, Elżbieta Semik-Grabarczyk, Barbara Zahorska‐Markiewicz · 2016 · International Journal of Medical Sciences
46. The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review
    Roosmarijn F.H. Lemmers, Mandy van Hoek, Aloysius G. Lieverse, Adrie J.M. Verhoeven, Eric J.G. Sijbrands, Monique T Mulder · 2017 · Journal of clinical lipidology
47. Impaired antioxidant HDL function is associated with premature myocardial infarction
    Klaus Distelmaier, Franz Wiesbauer, Hermann Blessberger, Stanislav Oravec, Lore Schrutka, Christina Binder, Elisabeth Dostal, Martin Schillinger, Johann Wojta, Irene Marthe Lang et al. · 2015 · European Journal of Clinical Investigation
48. Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
    Prahlad Rao, Kate Merath, Eugene I. Drigalenko, Avinash Y. L. Jadhav, RICHARD A. KOMOROWSKI, Matthew I. Goldblatt, Anand K. Rohatgi, Mark A. Sarzynski, Samer Gawrieh, Michael Olivier · 2018 · Clinical Proteomics
49. Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure
    Lore Schrutka, Klaus Distelmaier, Philipp J. Hohensinner, Patrick Sulzgruber, Irene Marthe Lang, Gerald Maurer, Johann Wojta, Martin Hülsmann, Alexander Niessner, Lorenz Koller · 2016 · Journal of the American Heart Association
50. Lipoproteins in Atherosclerosis Process
    Valentina Arnao, Antonino Tuttolomondo, Mario Daidone, Antonio Ventura Pinto · 2019 · Current Medicinal Chemistry
51. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
    Veronika Vyletelová, Mária Nováková, Ľudmila Pašková · 2022 · Pharmaceuticals
52. The bumpy road to evidence: why many research findings are lost in translation
    Thomas Felix Lüscher · 2013 · European Heart Journal
53. HDLs and the pathogenesis of atherosclerosis
    Adel Giaid Schwertani, Hong Y. Choi, Jacques J. Genest · 2018 · Current Opinion in Cardiology
54. Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity
    Idoia Genua, Núria Puig, Inka Miñambres, Sònia Benı́tez, Pedro Gil, M. Grau-Agramunt, Andrea Rivas-Urbina, Carmen Balagué Ponz, Sonia Fernández–Ananín, Álvaro García‐Osuna et al. · 2021 · Journal of Clinical Medicine
55. High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties
    Teja Klančič, Lavinia Woodward, Susanna M. Hofmann, Edward A A Fisher · 2016 · Molecular Metabolism
56. Clusterin is a Potential Therapeutic Target in Alzheimer’s Disease
    Nazhakaiti Palihati, Yuanhong Tang, Yajuan Yin, Ding Yu, Gang Liu, Zhenzhen Quan, Junjun Ni, Yan Yan, Hong Qing · 2023 · Molecular Neurobiology
57. High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility
    Laura Z. Vanags, Nathan K. P. Wong, Stephen James Nicholls, Christina A. Bursill · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
58. Understanding different facets of cardiovascular diseases based on model systems to human studies: A proteomic and metabolomic perspective
    Trayambak Basak, Swati Varshney, Shamima Akhtar, Shantanu Sengupta · 2015 · Journal of Proteomics
59. Factors associated with blood pressure disorders in Afro-descendant children and adolescents
    Fernando Rodrigues Peixoto Quaresma, Érika da Silva Maciel, Francisco Winter dos Santos Figueiredo, Fernando Adami · 2019 · BMC Pediatrics
60. Inflammation Alters Relationship Between High‐Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW‐CKD
    Jae Young Kim, Jung Tak Park, Hyung Woo Kim, Tae Ik Chang, Ea Wha Kang, Curie Ahn, Kook‐Hwan Oh, Joongyub Lee, Wookyung Chung, Yong‐Soo Kim et al. · 2021 · Journal of the American Heart Association
61. Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins
    Anna Rull, Maria Martínez-Bujidos, Montserrat Pérez‐Cuellar, Antonio Pérez, Jordi Ordóñez‐Llanos, José Luis Sánchez‐Quesada · 2015 · Atherosclerosis
62. Dissecting the proteome of lipoproteins: New biomarkers for cardiovascular diseases?
    Anne von Zychlinski, Torsten Kleffmann · 2015 · Translational Proteomics
63. Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice
    Susana Contreras‐Duarte, P. Chen, Marcelo E. Andía, Sergio A. Uribe, Pablo Irarrázaval M, Susanne Kopp, S. Kern, Gunther Marsche, Dolores Busso, Christian Wadsack et al. · 2018 · Biological Research
64. Progress in research on effect of PM 2.5 on occurrence and development of atherosclerosis
    Mengya Tian, Jingbo Zhao, Xingyan Mi, Kai Wang, Deling Kong, Hongjun Mao, Ting Wang · 2020 · Journal of Applied Toxicology
65. Dysfunctional HDL: the journey from savior to slayer
    Corina Serban, Danina Mirela Muntean, Dimitri P Mikhailids, Peter Paul Toth, Maciej Banach · 2014 · Clinical Lipidology
66. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
    Guisong Wang, Anna Vachaparampil Mathew, Haiyi Yu, Lei Li, Liyun He, Wei Dong Gao, Xiaodan Liu, Yanhong Guo, Jaeman Byun, Jifeng Zhang et al. · 2018 · PLoS ONE
67. The Role of Fine Particles (PM 2.5) in the Genesis of Atherosclerosis and Myocardial Damage: Emphasis on Clinical and Epidemiological Data, and Pathophysiological Mechanisms
    Aleksey Michailovich Chaulin, А.К. Сергеев · 2022 · Cardiology Research
68. Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD
    Ling Li, Gürkan Bebek, Stephen F. Previs, Jonathan D. Smith, Rovshan G. Sadygov, Arthur J. McCullough, Belinda B. Willard, Takhar Kasumov · 2016 · Journal of Proteome Research
69. Accelerated Age-Related Arterial Stiffness in Systemic Lupus Erythematosus Patients
    Fa ming Ding, Mengtao Li, Xinglin Yang, Yicong Ye, Lin Kang, Haiyu Pang, Qian Wang, Dong Xu, Xiaofeng Zeng, Shuyang Zhang · 2016 · JCR Journal of Clinical Rheumatology
70. Differential urinary proteins to diagnose coronary heart disease based on iTRAQ quantitative proteomics
    Haidan Sun, Danqi Wang, Dongfang Liu, Zhengguang Guo, Chen Shao, Wei Sun, Yong Zeng · 2019 · Analytical and Bioanalytical Chemistry
71. Antipsoriatic treatment extends beyond the skin: recovering of high‐density lipoprotein function
    Gunther Marsche, Michael Holzer, Peter Wolf · 2014 · Experimental Dermatology
72. Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase
    Branko Simic, Pavani Mocharla, Margot Crucet, Elena Osto, Adelheid Kratzer, Simona Stivala, Susan Kühnast, Thimoteus Speer, Petia Doycheva, Hans M. G. Princen et al. · 2017 · Atherosclerosis
73. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases
    Anouar Hafiane, Elda Favari, Stella Styliani Daskalopoulou, Nicolas Vuilleumier, Miguel A. Frias · 2020 · Metabolism
74. Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
    Esin Eren, Necat Yılmaz, Özgür Aydın, Hamit Yaşar Elli̇dağ · 2014 · The Open Biochemistry Journal
75. The difficult search for a ‘partner’ of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin
    Ulf Landmesser · 2013 · European Heart Journal
76. Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
    Andrea Rivas-Urbina, Anna Rull, Jordi Ordóñez‐Llanos, José Luis Sánchez‐Quesada · 2018 · Current Medicinal Chemistry
77. Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
    Jamie Morton, Shisan Bao, Laura Z. Vanags, Tania Tsatralis, Anisyah Ridiandries, Chung‐Wah Siu, Kwong‐Man Ng, Joanne T. M. Tan, David Stephen Celermajer, Martin Ng et al. · 2018 · JACC Basic to Translational Science
78. Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia
    Frank M. Sacks, Jeremy D. Furtado, Majken K. Jensen · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
79. Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability
    Gabriele Nieddu, Marilena Formato, Antonio Junior Lepedda · 2023 · International Journal of Molecular Sciences
80. New and Emerging Biomarkers in Cardiovascular Disease
    Leah E. Cahill, Monica L. Bertoia, Sarah A. Aroner, Kenneth Jay Mukamal, Majken K. Jensen · 2015 · Current Diabetes Reports
81. Network-Based Analysis on Orthogonal Separation of Human Plasma Uncovers Distinct High Density Lipoprotein Complexes
    Hailong Li, Scott M. Gordon, Xiaoting Zhu, Jingyuan Deng, Debi K. Swertfeger, William Sean Davidson, Long Jason Lu · 2015 · Journal of Proteome Research
82. Apoprotein C-III: A review of its clinical implications
    Jing‐Lu Jin, Yuan‐Lin Guo, Jian‐Jun Li · 2016 · Clinica Chimica Acta
83. Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells
    MIAO-QIAN SHI, Feifei Su, Xuan Xu, Xiongtao Liu, HONG-TAO WANG, Wei Zhang, Xue Li, CHENG LIAN, Qiangsun Zheng, Zhichun Feng · 2016 · Molecular Medicine Reports
84. HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study
    Manja Koch, Sarah A. Aroner, Annette L. Fitzpatrick, W.T. Longstreth, Jeremy D. Furtado, Kenneth Jay Mukamal, Majken K. Jensen · 2021 · Stroke
85. Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high‐density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus
    Gabriela Maria Sanda, Laura Toma, Teodora Barbălată, Oriana E. Moraru, Loredan Stefan Niculescu, Anca Volumnia Sima, Camelia Sorina Stancu · 2021 · BioFactors
86. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
    Chiz-Tzung Chang, Chao‐Yuh Yang, Fuu‐Jen Tsai, Shih-Yi Lin, Chao‐Jung Chen · 2015 · BioMed Research International
87. Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer
    Qingqing Lin, Wenchao Liu, Xu Song, Liping Sun · 2021 · Archives of Gynecology and Obstetrics
88. Development of Antisense Drugs for Dyslipidemia
    Tsuyoshi Yamamoto, Fumito Wada, Mariko Harada‐Shiba · 2016 · Journal of Atherosclerosis and Thrombosis
89. Altered proteome of high-density lipoproteins from paediatric acute lymphoblastic leukemia survivors
    Maryse Fournier, Éric Bonneil, Carole Garofalo, Guy Grimard, Caroline Laverdière, Maja Krajinović, Simon Drouin, Daniel Sinnett, Valérie Marcil, Emile H. Levy · 2019 · Scientific Reports
90. HDL’s Protein Cargo
    Jay W. Heinecke · 2013 · Circulation
91. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia
    Tianhua Zhang, Xiaoyu Tang, Ling Mao, Jin Chen, Jie Kuang, Xin Guo, Danyan Xu, Daoquan Peng, Bilian Yu · 2020 · Clinical Biochemistry
92. HDL Quality Features Revealed by Proteome-Lipidome Connectivity Are Associated with Atherosclerotic Disease
    Dandan Wang, Bilian Yu, Qingrun Li, Yanhong Guo, Tomonari Koike, Yui Koike, Qingqing Wu, Jifeng Zhang, Ling Mao, Xiaoyu Tang et al. · 2020 · Journal of Molecular Cell Biology
93. High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
    Wenke Cheng, Maciej Rosołowski, Julia Boettner, Steffen Desch, Alexander Jobs, Hölger Thiele, Petra G Buttner · 2022 · Lipids in Health and Disease
94. APOA II genotypes frequency and their interaction with saturated fatty acids consumption on lipid profile of patients with type 2 diabetes
    Neda Noorshahi, Gity Sotoudeh, Mahmoud Djalali, Mohamad Reza Eshraghian, Mohammad Keramatipour, Marjan Ghane Basiri, Farideh Doostan, Fariba Koohdani · 2015 · Clinical Nutrition
95. Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome
    William F. Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, Sora Lecocq, M. John Chapman, Daniel James Rader, Anatol Kontush, Marina Cuchel · 2017 · Journal of clinical lipidology
96. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease—A Proteome Analysis of Cerebrospinal Fluid
    Daina Kashiwazaki, 内野晴登, Satoshi Kuroda · 2017 · Journal of Stroke and Cerebrovascular Diseases
97. Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients
    Yasunori Suematsu, Masaki Goto, Christina Park, Ane Cláudia Fernandes Nunes, Wanghui Jing, Elani Streja, Connie M. Rhee, Siobanth Cruz, Moti L. Kashyap, Nosratola D. Vaziri et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
98. Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events
    Judit Cubedo, Teresa Padró, Gemma Vilahur, Filippo Crea, Robert F. Storey, José Luis López Sendón, Juan Carlos Kaski, Alessandro Sionís, Jordi Sans‐Roselló, Estefanıa Fernández‐Peregrina et al. · 2021 · European Heart Journal
99. HDL and Endothelial Function
    Yufei Wu, Yangkai Xu, Jie Chen, Mingming Zhao, Kerry‐Anne Rye · 2022 · Advances in experimental medicine and biology
100. Global research trends in atherosclerosis: A bibliometric and visualized study
     Wende Tian, Tai Zhang, Xinyi Wang, Jie Zhang, Jianqing Ju, Hao Xu · 2022 · Frontiers in Cardiovascular Medicine